| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/22/2014 | CN103520126A Almotriptan tablet and preparation method thereof |
| 01/22/2014 | CN103520095A Gastrodin injection and preparation process thereof |
| 01/22/2014 | CN103519173A Preparation method of three-ginseng body nourishing oral liquid |
| 01/22/2014 | CN103519167A Instant asparagus powder food with new applications of relieving pressure and improving memory |
| 01/22/2014 | CN103127175B Antiepileptic medicine and preparation method thereof |
| 01/22/2014 | CN103027138B Tea for enlivening spleens and production method of tea |
| 01/22/2014 | CN103025705B Polymorphs of 4-[2-dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenyl 4-methylbenzoate hydrochloride, methods for preparing the same and use of the same |
| 01/22/2014 | CN102920927B Chinese medicinal composition for treating fresh traumatic paraplegia |
| 01/22/2014 | CN102847164B Application of chrysalis oil in improving small molecule drug bioavailability |
| 01/22/2014 | CN102824523B Method of preparing traditional Chinese medicine lotion for treating headache type closed fracture |
| 01/22/2014 | CN102793890B Chinese patent medicine for treating yang epilepsy |
| 01/22/2014 | CN102753540B A4ss2 neuronal nicotinic acetylcholine receptor ligands |
| 01/22/2014 | CN102600374B Medicine for preventing parkinsonism and application of medicine |
| 01/22/2014 | CN102600373B Traditional Chinese medicine composition for relieving parkinsonism motion complications |
| 01/22/2014 | CN102600372B Chinese medicinal composition for preventing Parkinsonism |
| 01/22/2014 | CN102600371B Traditional Chinese medicine composition for preventing parkinsonism and application of traditional Chinese medicine composition |
| 01/22/2014 | CN102579934B Traditional Chinese medical composition used for treatment of vascular dementia and preparation and application thereof |
| 01/22/2014 | CN102512636B Chinese medicinal herb for treating tristimania and preparation method thereof |
| 01/22/2014 | CN102224136B 3-phenyl-3-methoxypyrrolidine derivatives as modulators of cortical catecholaminergic neurotransmission |
| 01/22/2014 | CN102124001B Derivatives of 2-oxo-alkyl-1-piperazin-2-one, preparation method thereof and therapeutic use of same |
| 01/22/2014 | CN102099358B Compound with serotoninergic activity, process for preparing same and pharmaceutical composition comprising same |
| 01/22/2014 | CN102079717B Arginine salt compound of dibasic ester acids and preparation method and medicinal application thereof |
| 01/22/2014 | CN101874817B Brucea javanica oil enteric-coated microcapsule and preparation method |
| 01/22/2014 | CN101842369B 2, 3-dihydrobenzo[1, 4] dioxin-2-ylmethyl derivatives as alpha2c antagonists for use in the treatment of peripheric and central nervous systeme diseases |
| 01/21/2014 | US8633235 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 01/21/2014 | US8633218 8-azabicyclo[3.2.1]oct-2-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 01/21/2014 | US8633210 Triazole compounds useful as protein kinase inhibitors |
| 01/21/2014 | US8633205 Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of protein kinases |
| 01/21/2014 | US8633160 Small molecule inhibitors of PDZ interactions |
| 01/21/2014 | US8632824 Process of obtaining thylakoids from photosynthetic organisms; plant fractions obtained from the process; pure thylakoids; and methods of use of thylakoids as ROS scavengers, photo-protectors, biosensors, biofilters and bioreactors |
| 01/21/2014 | US8632821 Use of xenon for treating hypersensitivity to pain |
| 01/21/2014 | US8632798 Cereal β glucan compositions, methods of preparation and uses thereof |
| 01/21/2014 | US8632750 Methods for recommending neurophysiological disorder therapy |
| 01/21/2014 | CA2698396C Interferon alpha2a modified by polyethylene glycol, the preparation and use thereof |
| 01/21/2014 | CA2671000C Method for suppressing coloring of adhesive preparation containing donepezil and method for reducing amounts of donepezil-related substances formed |
| 01/21/2014 | CA2665748C Immunogenic peptide composition for the prevention and treatment of alzheimer's disease |
| 01/21/2014 | CA2595115C Fusion proteins for treating, preventing or ameliorating pain |
| 01/21/2014 | CA2484398C Method for reducing pain using oncolytic viruses |
| 01/21/2014 | CA2446723C Antibodies that immunospecifically bind to trail receptors |
| 01/21/2014 | CA2359317C Method of treating restenosis by antisense targeting of c-myc |
| 01/21/2014 | CA2341763C Antigenic peptides of aglyco 10b and antibodies thereto |
| 01/16/2014 | WO2014012063A1 Pharmaceutical dosage forms comprising ecopipam free base or pharmaceutically acceptable salts thereof |
| 01/16/2014 | WO2014012034A1 Fused benzazepines for treatment of tourette's syndrome |
| 01/16/2014 | WO2014011827A1 Treatment of multiple sclerosis with combination of laquinimod and fampridine |
| 01/16/2014 | WO2014011768A1 Anti-anxiety treatment |
| 01/16/2014 | WO2014011754A1 Novel 1, 4-benzoxazinone compounds |
| 01/16/2014 | WO2014011461A1 Amide or urea substituted benzothiazole derivatives as inhibitors of endothelial lipase |
| 01/16/2014 | WO2014011209A1 Compositions and methods of use of phorbol esters for the treatment of stroke |
| 01/16/2014 | WO2014011085A1 Agent exhibiting antioxidant, anti-inflammatory, neuroprotective, hypolipidemic, hypocholesterolemic, hypoglycemic, hepatoprotective and immunosuppressive activities |
| 01/16/2014 | WO2014011047A1 Chromanyl derivatives for treating mitochondrial disease |
| 01/16/2014 | WO2014010748A1 Cyclopropane derivative having bace1 inhibiting activity |
| 01/16/2014 | WO2014010732A1 Heterocyclic compound |
| 01/16/2014 | WO2014010657A1 Processed nutmeg product and method for producing same |
| 01/16/2014 | WO2014009936A1 Compositions for the treatment of neuropathic pain |
| 01/16/2014 | WO2014009305A1 Inhibitors of phosphodiesterase 10 enzyme |
| 01/16/2014 | WO2014008692A1 Ketogenic diet formula milk and preparation method thereof |
| 01/16/2014 | WO2014008648A1 A composition comprising reduced glutathione and acetaminophen and preparation method thereof |
| 01/16/2014 | WO2014008629A1 Novel derivatives of donepezil |
| 01/16/2014 | US20140017742 Preparation of microbial oil |
| 01/16/2014 | US20140017343 Method for manufacturing drugs that enhance brain function |
| 01/16/2014 | CA2876512A1 Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof |
| 01/16/2014 | CA2876499A1 Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof |
| 01/16/2014 | CA2875057A1 Inhibitors of phosphodiesterase 10 enzyme |
| 01/16/2014 | CA2862301A1 Compositions and methods of use of phorbol esters for the treatment of stroke |
| 01/15/2014 | EP2684878A1 Dipyridylamine derivative |
| 01/15/2014 | EP2684873A1 Drugs for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases |
| 01/15/2014 | EP2684871A1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives |
| 01/15/2014 | EP2684572A1 Adjuvant composition containing citrulline |
| 01/15/2014 | EP2684561A1 Tablet-type composition for oral administration and method for producing same |
| 01/15/2014 | EP2683738A1 Anti oligomer antibodies and uses thereof |
| 01/15/2014 | EP2683733A1 Tfeb variants and uses thereof |
| 01/15/2014 | EP2683721A1 3,4-DIHYDRO-PYRROLO[1,2-a]PYRAZIN-1-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE) |
| 01/15/2014 | EP2683719A1 SUBSTITUTED [(5H-PYRROLO[2,1-c] [1,4]BENZODIAZEPIN-11-YL)PIPERAZIN-1-YL]-2,2-DIMETHYLPROPANOIC ACID COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5-HT2A ANTAGONISTS |
| 01/15/2014 | EP2683710A1 Soluble guanylate cyclase activators |
| 01/15/2014 | EP2683690A1 Quinolinone derivatives |
| 01/15/2014 | EP2683444A1 Tfeb phosphorylation inhibitors and uses thereof |
| 01/15/2014 | EP2683404A1 The method of treating amyotrophic lateral sclerosis |
| 01/15/2014 | EP2683391A1 Method for treating neurodegenerative tauopathy |
| 01/15/2014 | EP2683373A1 Orthomolecular agent for countering the consequences of alcohol consumption |
| 01/15/2014 | EP2683245A1 Methods and compositions for treating depression using cyclobenzaprine |
| 01/15/2014 | EP2683242A1 Effective amounts of (3ar)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate and methods thereof |
| 01/15/2014 | CN103517901A 1,4-oxazepines as bace1 and/or bace2 inhibitors |
| 01/15/2014 | CN103517896A Quinolinone derivatives |
| 01/15/2014 | CN103517712A Neuropeptide analogs, compositions, and methods for treating pain |
| 01/15/2014 | CN103509675A Preparation method of health-care apple-juice tea wine |
| 01/15/2014 | CN103509116A 抗体纯化 Antibody Purification |
| 01/15/2014 | CN103509073A Citicoline sodium compound |
| 01/15/2014 | CN103509071A Preparation and application of active ingredients of glossy privet fruit |
| 01/15/2014 | CN103509017A Substituted pyrazolo[1,5-a]pyrimidine compounds as TRK kinase inhibitors |
| 01/15/2014 | CN103508988A Preparation of new bakkenolide type sesquiterpene and application thereof |
| 01/15/2014 | CN103508960A Benzoheterocyclic derivatives |
| 01/15/2014 | CN103508957A Hydroxyethyl pyrazole compound or aminoethyl pyrazole compound, preparation method and use thereof |
| 01/15/2014 | CN103508953A Salts of nuciferine derivatives |
| 01/15/2014 | CN103508952A Salts of N-nornuciferine derivatives |
| 01/15/2014 | CN103508951A Salts of 2-hydroxy-1-methoxyaporphine derivative |
| 01/15/2014 | CN103508943A Compound taken as potassium channel regulator |
| 01/15/2014 | CN103508931A Hexahydropentaleno derivatives, preparation methods and applications in medicine thereof |
| 01/15/2014 | CN103505744A Gene delivery system of targeting brain capillary endothelial cell |
| 01/15/2014 | CN103505743A Cell micro-particles containing functional microRNA/siRNA and application thereof |
| 01/15/2014 | CN103505735A Composition containing r-aminobutyric acid, taurine and antiepileptic drugs |